Wasatch Advisors’s MEI Pharma MEIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-467,116
| Closed | -$24.9M | – | 271 |
|
|
2021
Q4 | $24.9M | Buy |
467,116
+150,129
| +47% | +$8.02M | 0.1% | 156 |
|
|
2021
Q3 | $17.5M | Sell |
316,987
-14,971
| -5% | -$826K | 0.07% | 179 |
|
|
2021
Q2 | $18.9M | Sell |
331,958
-1,162
| -0.3% | -$66.2K | 0.08% | 184 |
|
|
2021
Q1 | $22.9M | Buy |
333,120
+55,832
| +20% | +$3.83M | 0.1% | 165 |
|
|
2020
Q4 | $14.6M | Buy |
277,288
+27,099
| +11% | +$1.43M | 0.07% | 165 |
|
|
2020
Q3 | $15.6M | Buy |
250,189
+33,119
| +15% | +$2.07M | 0.1% | 146 |
|
|
2020
Q2 | $17.9M | Sell |
217,070
-36,466
| -14% | -$3.01M | 0.13% | 130 |
|
|
2020
Q1 | $8.16M | Buy |
253,536
+32,778
| +15% | +$1.06M | 0.09% | 142 |
|
|
2019
Q4 | $11M | Buy |
220,758
+137,500
| +165% | +$6.82M | 0.09% | 144 |
|
|
2019
Q3 | $2.8M | Buy |
83,258
+18,951
| +29% | +$637K | 0.03% | 222 |
|
|
2019
Q2 | $3.22M | Buy |
64,307
+8,828
| +16% | +$441K | 0.03% | 209 |
|
|
2019
Q1 | $3.41M | Buy |
55,479
+19,027
| +52% | +$1.17M | 0.04% | 196 |
|
|
2018
Q4 | $1.93M | Buy |
36,452
+20,695
| +131% | +$1.09M | 0.03% | 211 |
|
|
2018
Q3 | $1.36M | Buy |
15,757
+3,033
| +24% | +$261K | 0.02% | 224 |
|
|
2018
Q2 | $1M | Buy |
+12,724
| New | +$1M | 0.01% | 249 |
|
|
2017
Q4 | – | Sell |
-11,905
| Closed | -$638K | – | 310 |
|
|
2017
Q3 | $638K | Sell |
11,905
-783
| -6% | -$42K | 0.01% | 294 |
|
|
2017
Q2 | $606K | Hold |
12,688
| – | – | 0.01% | 318 |
|
|
2017
Q1 | $411K | Hold |
12,688
| – | – | 0.01% | 328 |
|
|
2016
Q4 | $365K | Hold |
12,688
| – | – | 0.01% | 346 |
|
|
2016
Q3 | $447K | Hold |
12,688
| – | – | 0.01% | 336 |
|
|
2016
Q2 | $345K | Sell |
12,688
-411
| -3% | -$11.2K | 0.01% | 355 |
|
|
2016
Q1 | $333K | Hold |
13,099
| – | – | 0.01% | 354 |
|
|
2015
Q4 | $419K | Buy |
+13,099
| New | +$419K | 0.01% | 356 |
|